This inventor holds 1 USPTO granted patent. Top assignee: Koninklijke Philips Corporation N.v.. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Huibin Wei - Innovator in Respiratory Disease Monitoring
Introduction
Huibin Wei is a notable inventor based in Shanghai, China. He has made significant contributions to the field of respiratory disease monitoring, particularly for allergic asthma patients. His innovative approach focuses on unobtrusive methods to assess and manage exacerbation risks associated with respiratory conditions.
Latest Patents
Huibin Wei holds a patent for "Unobtrusive symptoms monitoring for allergic asthma patients." This invention relates to a system and method that provides an exacerbation risk score for patients suffering from respiratory diseases. The system measures heart signals and blood circulation signals, detecting cough and sneeze events in the measurement data. These events are indicative of potential contagions or allergies that could exacerbate the patient's respiratory condition. The system is designed to provide an unobtrusive exacerbation risk score to both the patient and their physician.
Career Highlights
Huibin Wei is currently employed at Koninklijke Philips Corporation N.V., where he continues to develop innovative solutions in healthcare technology. His work emphasizes the importance of monitoring respiratory health and improving patient outcomes through advanced technology.
Collaborations
Some of Huibin Wei's coworkers include Mirela Alina Weffers-Albu and Declan Patrick Kelly. Their collaborative efforts contribute to the advancement of healthcare technologies and innovations.
Conclusion
Huibin Wei's contributions to the field of respiratory disease monitoring highlight the importance of innovation in healthcare. His patent for unobtrusive symptoms monitoring represents a significant step forward in managing allergic asthma, ultimately benefiting patients and healthcare providers alike.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
